WD-FARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
WD-FARMA
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€62,401
2024 · €69,673-€7,272
Equity
€479,404
2024 · €475,313+€4,092
Cash
€151,342
2024 · €134,714+€16,628
Balance sheet total
€787,913
2024 · €829,372-€41,459
Largest movements
Assets
- Receivables within one year -€38,525
down €38,525 (-9.1%), from €424,623 to €386,098
of which Trade receivables: -€40,943
- Tangible fixed assets -€22,564
down €22,564 (-15.9%), from €141,629 to €119,065
- Cash +€16,628
up €16,628 (+12.3%), from €134,714 to €151,342
mainly Net result for the year (+€62,401) and Receivables within one year (+€38,525)
Equity and liabilities
- Trade debts -€29,074
down €29,074 (-22.7%), from €128,095 to €99,021
- Debts after one year -€16,423
down €16,423 (-12.2%), from €135,017 to €118,594
Income statement
- Gross operating margin -€10,615
down €10,615 (-5.6%), from €189,753 to €179,138
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€69,673
Gross operating margin
-€10,615
Staff costs
+€1,293
Depreciation
+€1,151
Other operating charges
-€41
Financial income
+€1,564
Financial charges
+€871
Taxes
-€1,494
Result 2025
€62,401
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€93,284
Investment
-€2,554
Financing
-€74,101
Cash 2024
€134,714
From operations (derived)
+€93,284
Net result for the year
+€62,401
Depreciation
+€25,308
Stocks and contracts
+€1,694
Receivables within one year
+€38,525
Deferred charges and accrued income
-€4,886
Trade debts
-€29,074
Tax, wage and social debts
+€6,656
Other debts
-€7,283
Accrued charges and deferred income
-€57
Investment (derived)
-€2,554
Investment in fixed assets (net)
-€2,554
Financing
-€74,101
Debts after one year
-€16,423
Current portion of long-term debt
+€631
Contributions, distributions and other
-€58,309
Cash 2025
€151,342
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €829,372 | €787,913 | -€41,459 | -5.0% |
| Fixed assets | 21/28 | €141,819 | €119,065 | -€22,754 | -16.0% |
| Intangible fixed assets | 21 | €190 | €0 | -€190 | -100% |
| Tangible fixed assets | 22/27 | €141,629 | €119,065 | -€22,564 | -15.9% |
| Plant, machinery and equipment | 23 | €141,629 | €119,065 | -€22,564 | -15.9% |
| Current assets | 29/58 | €687,553 | €668,848 | -€18,705 | -2.7% |
| Stocks and contracts in progress | 3 | €125,397 | €123,702 | -€1,694 | -1.4% |
| Stocks | 30/36 | €125,397 | €123,702 | -€1,694 | -1.4% |
| Amounts receivable within one year | 40/41 | €424,623 | €386,098 | -€38,525 | -9.1% |
| Trade receivables | 40 | €159,003 | €118,060 | -€40,943 | -25.7% |
| Other amounts receivable | 41 | €265,620 | €268,038 | +€2,418 | +0.9% |
| Cash at bank and in hand | 54/58 | €134,714 | €151,342 | +€16,628 | +12.3% |
| Deferred charges and accrued income | 490/1 | €2,820 | €7,706 | +€4,886 | +173% |
| Total equity and liabilities | 10/49 | €829,372 | €787,913 | -€41,459 | -5.0% |
| Equity | 10/15 | €475,313 | €479,404 | +€4,092 | +0.9% |
| Contributions | 10/11 | €250,704 | €250,704 | = | 0.0% |
| Reserves | 13 | €224,609 | €228,700 | +€4,092 | +1.8% |
| Tax-exempt reserves | 132 | €936 | €936 | = | 0.0% |
| Distributable reserves | 133 | €223,673 | €227,764 | +€4,092 | +1.8% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €354,060 | €308,509 | -€45,551 | -12.9% |
| Amounts payable after more than one year | 17 | €135,017 | €118,594 | -€16,423 | -12.2% |
| Financial debts | 170/4 | €135,017 | €118,594 | -€16,423 | -12.2% |
| Amounts payable within one year | 42/48 | €218,986 | €189,915 | -€29,071 | -13.3% |
| Current portion of amounts payable after more than one year | 42 | €15,792 | €16,423 | +€631 | +4.0% |
| Trade debts | 44 | €128,095 | €99,021 | -€29,074 | -22.7% |
| Suppliers | 440/4 | €128,095 | €99,021 | -€29,074 | -22.7% |
| Taxes, remuneration and social security | 45 | €6,742 | €13,398 | +€6,656 | +98.7% |
| Taxes | 450/3 | €290 | €142 | -€148 | -51.1% |
| Remuneration and social security | 454/9 | €6,452 | €13,256 | +€6,804 | +105% |
| Other amounts payable | 47/48 | €68,356 | €61,073 | -€7,283 | -10.7% |
| Accrued charges and deferred income | 492/3 | €57 | €0 | -€57 | -100% |
| Remuneration, social security and pensions | 62 | €96,192 | €94,898 | -€1,293 | -1.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €26,459 | €25,308 | -€1,151 | -4.3% |
| Other operating charges | 640/8 | €862 | €904 | +€41 | +4.8% |
| Gross operating margin | 9900 | €189,753 | €179,138 | -€10,615 | -5.6% |
| Operating profit (loss) | 9901 | €66,240 | €58,028 | -€8,212 | -12.4% |
| Financial income | 75/76B | €11,475 | €13,039 | +€1,564 | +13.6% |
| Recurring financial income | 75 | €11,475 | €13,039 | +€1,564 | +13.6% |
| Financial charges | 65/66B | €6,965 | €6,095 | -€871 | -12.5% |
| Recurring financial charges | 65 | €6,965 | €6,095 | -€871 | -12.5% |
| Profit (loss) for the period before taxes | 9903 | €70,750 | €64,972 | -€5,778 | -8.2% |
| Income taxes | 67/77 | €1,078 | €2,572 | +€1,494 | +139% |
| Profit (loss) for the period | 9904 | €69,673 | €62,401 | -€7,272 | -10.4% |
| Profit (loss) for the period to be appropriated | 9905 | €69,673 | €62,401 | -€7,272 | -10.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.